Page last updated: 2024-12-07
kg 501
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
naphthol AS-E phosphate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 87517 |
| CHEMBL ID | 1234585 |
| SCHEMBL ID | 11979377 |
| MeSH ID | M0480221 |
Synonyms (37)
| Synonym |
|---|
| CHEMBL1234585 |
| n3p , |
| n-(4-chlorophenyl)-3-(phosphonooxy)naphthalene-2-carboxamide |
| naphthol as-e phosphate |
| DB08240 |
| 18228-17-6 |
| nsc746568 |
| nsc-746568 |
| [3-[(4-chlorophenyl)carbamoyl]naphthalen-2-yl] dihydrogen phosphate |
| naphtholas-ephosphate |
| unii-h6r6b93qfc |
| h6r6b93qfc , |
| einecs 242-106-1 |
| nsc 746568 |
| kg 501 |
| kg-501 |
| S8409 |
| AKOS024375425 |
| SCHEMBL11979377 |
| DTXSID10171275 |
| naphthol as-e phosphate, for histology |
| mfcd00042718 |
| CS-0027313 |
| HY-103299 |
| 3-(4-chlorophenylcarbamoyl)naphthalen-2-yl dihydrogen phosphate |
| 3-[(4-chlorophenyl)carbamoyl]naphthalen-2-yl dihydrogen phosphate |
| FT-0712758 |
| kg-501(naphthol as-e phosphate) |
| Q27097463 |
| HMS3886J10 |
| BCP29194 |
| EX-A2026 |
| C73512 |
| 3-((4-chlorophenyl)carbamoyl)naphthalen-2-yl dihydrogen phosphate , |
| kg-501 (2-naphthol-as-e-phosphate) |
| AC-35586 |
| dibenzylterephthalate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1413754 | Inhibition of [32P]-labeled CREB KID (unknown origin) binding to GST-fused mouse CBP KIX domain preincubated with GST-fused CBP for 15 mins followed by CREB addition and measured after 30 mins by SDS-gel electrophoresis/autoradiographic method | 2018 | MedChemComm, Aug-01, Volume: 9, Issue:8 | Chemical modulation of transcription factors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (12)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 39.43
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (39.43) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (8.33%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (91.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||